Medical News

RSS

Positive data from BioSante Pharmaceuticals' LibiGel Phase III clinical development program

BioSante Pharmaceuticals, Inc., today announced positive safety data in its ongoing LibiGel Phase III clinical development program. For the first time, unblinded data have been reviewed by the independent DMC of the LibiGel Cardiovascular and Breast Cancer Safety Study. Based on this review of unblinded data, the DMC unanimously recommended continuation of the study as described in the study protocol, with no modifications.

20 Oct 2009

National Health Partners adds third marketing firm to its internet marketing campaign

National Health Partners, Inc. (National Health) (OTCBB: NHPR), a leading provider of unique discount healthcare membership programs, announced today that it has added a third leading marketing firm to its internet marketing campaign.

20 Oct 2009

Sojourns Award to recognize leadership in palliative care industry

The Regence Foundation has announced a new award that recognizes leadership in palliative care, a specialized field of health care that relieves suffering and improves quality of life for patients with advanced illness.

20 Oct 2009

Human Rights and Oversight to hold a hearing on international violence against women

On Wednesday, October 21 at 2:00 p.m. in Rayburn House Office Building, Room 2172, Chairman Delahunt (D-MA) of the House Foreign Affairs Subcommittee on International Organizations, Human Rights and Oversight will hold a hearing titled International Violence Against Women: Stories and Solutions.

20 Oct 2009

Targacept presents data from Phase 2b clinical trial of TC-5214

Targacept, Inc., a clinical-stage biopharmaceutical company developing a new class of drugs known as NNR Therapeutics-, today announced the presentation of data from its recently completed Phase 2b clinical trial of TC-5214 as an augmentation (add-on) treatment in subjects with major depressive disorder, or MDD, who did not respond adequately to first-line treatment with the representative SSRI citalopram hydrobromide.

20 Oct 2009

FTC Red Flags Rule compliance with message encryption

With the deadline for compliance with the Federal Trade Commission's (FTC) Red Flags Rule looming, one Colorado Internet company is providing a simple solution -- encrypt your messages.

20 Oct 2009

Complimentary book for fertility patients placing first fertility cycle order

Village Fertility Pharmacy (www.villagefertilitypharmacy.com), a specialty pharmacy focused exclusively on infertility medications, is pleased to announce that, effectively immediately, fertility patients who place a fertility cycle order for the first time will receive a complimentary copy of Kristen Magnacca's award-winning book, "Love and Infertility: Strategies for Survival - Balancing Infertility, Marriage, and Life."

20 Oct 2009

Brandeis psychologist receives the 2009 Baltes Foundation Award

The Gerontological Society of America (GSA) - the nation's largest interdisciplinary organization devoted to the field of aging - has chosen Brandeis University Professor Derek M. Isaacowitz, as the 2009 recipient of the Margret M. & Paul B. Baltes Foundation Award in Behavioral and Social Gerontology.

20 Oct 2009

Human neural stem cells protect cone photoreceptors: StemCells preclinical data

StemCells, Inc. announced today new preclinical data showing that its human neural stem cells protect cone photoreceptors (cones) in the eye from progressive degeneration and preserve visual function long term.

20 Oct 2009

Report: National investment on childhood and adolescent cancer research

The first-ever detailed examination of a country's investment in research on childhood and adolescent cancers was released today by the Canadian Cancer Research Alliance (CCRA) and the Canadian Partnership Against Cancer (the Partnership).

20 Oct 2009

Researchers use biotechnological tools to find a cure for Alzheimer's disease

No one has yet found a cure or a way to prevent people from developing Alzheimer's disease. Researchers from the Swedish University of Agricultural Sciences, among others, are breaking new ground in biotechnology to find new tools that can help provide new solutions.

20 Oct 2009

ImPACKD calls for raising awareness about the risks of calcium overuse in CKD patients

Most Canadians living with CKD have likely never spoken with their physicians about calcium and the serious health risks associated with its overuse. This is why Improving Patient Advocacy in Chronic Kidney Disease (ImPACKD), a group of CKD patients and caregivers committed to raising awareness about the risks of calcium overuse, is starting the conversation about the importance of knowing the limits and keeping them in check.

20 Oct 2009

Smoothduck releases new Windows software to speed up file search

Smoothduck Inc. has just released its new Windows software product, Where'sMyStuff?, designed to simplify and speed the tasks of finding and organizing files on PCs.

20 Oct 2009

Vertos Medical raises $15.5 million for U.S. commercialization of the company’s "mild" technology

Medical device company Vertos Medical, Inc., developer of the mild® procedure for lumbar spinal stenosis (LSS), today announced it has completed a $15.5 million Series D financing. New investor, ONSET Ventures, led the round with additional participation from existing Vertos investors CHL Medical Partners, Foundation Medical Partners, Aweida Venture Partners and DFJ Mercury.

20 Oct 2009

Pfizer announces fiscal 2009 third-quarter results

Pfizer Inc. today reported financial results for third-quarter 2009. Revenues were $11.6 billion, a decrease of 3% compared with $12.0 billion in the year-ago quarter.

20 Oct 2009

Women without HOXA13 gene mutation need not be subjected to X-rays

Hugh S. Taylor, M.D., professor in the Department of Obstetrics, Gynecology & Reproductive Sciences at Yale, and colleagues have found that women without mutations of the HOXA13 gene do not need to be subjected to x-rays and other tests for a rare condition called hand-foot genital syndrome. The research is presented at the American Society for Reproductive Medicine (ASRM) scientific meeting in Atlanta, Georgia, October 17-21.

20 Oct 2009

TechniScan becomes publicly traded company through reverse merger with Castillo

TechniScan, Inc. (OTCBB: TSNI) (“TechniScan” or the “Company”), a medical device company engaged in the development and commercialization of an automated breast ultrasound imaging system, has become a publicly traded company through a reverse merger with and into Castillo, Inc., a Delaware corporation.

20 Oct 2009

Merck Frosst Canada announces the use of ISENTRESS for treating HIV-1 infected adults

Merck Frosst Canada Ltd. is pleased to announce that (Pr)ISENTRESS(R) (raltegravir) is now indicated for use in treatment-naïve HIV-1 infected adults in combination with other antiretroviral agents.

20 Oct 2009

Boehringer Ingelheim continues providing non assert declarations to manufacture HIV/AIDS medicines

Boehringer Ingelheim continues to be willing to provide WHO qualified generic pharmaceutical companies non assert declarations to manufacturer and export products containing the HIV/AIDS medication nevirapine to Rwanda and other defined developing countries.

20 Oct 2009

TechnoVax receives NIH grant to further the development of its VLP-based, vaccine program

TechnoVax, Inc., a biotechnology developer of novel vaccines was awarded a three-year $2.9 million SBIR phase II grant from the National Institutes of Health to further the development of its VLP-based, vaccine program.

20 Oct 2009

Medical News

Positive data from BioSante Pharmaceuticals' LibiGel Phase III clinical development program

National Health Partners adds third marketing firm to its internet marketing campaign

Sojourns Award to recognize leadership in palliative care industry

Human Rights and Oversight to hold a hearing on international violence against women

Targacept presents data from Phase 2b clinical trial of TC-5214

FTC Red Flags Rule compliance with message encryption

Complimentary book for fertility patients placing first fertility cycle order

Brandeis psychologist receives the 2009 Baltes Foundation Award

Human neural stem cells protect cone photoreceptors: StemCells preclinical data

Report: National investment on childhood and adolescent cancer research

Researchers use biotechnological tools to find a cure for Alzheimer's disease

ImPACKD calls for raising awareness about the risks of calcium overuse in CKD patients

Smoothduck releases new Windows software to speed up file search

Vertos Medical raises $15.5 million for U.S. commercialization of the company’s "mild" technology

Pfizer announces fiscal 2009 third-quarter results

Women without HOXA13 gene mutation need not be subjected to X-rays

TechniScan becomes publicly traded company through reverse merger with Castillo

Merck Frosst Canada announces the use of ISENTRESS for treating HIV-1 infected adults

Boehringer Ingelheim continues providing non assert declarations to manufacture HIV/AIDS medicines

TechnoVax receives NIH grant to further the development of its VLP-based, vaccine program

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News